Want to join the conversation?
$CTXS raised its FY16 net revenue outlook to range of $3.37-3.39Bil from prior forecast of $3.34-3.36Bil. The company also lifted FY16 GAAP EPS guidance to range of $2.86-2.99 from previous estimate of $2.75-2.90 and its non-GAAP EPS projection to range of $5.00-5.10 from prior range of $4.90-5.00.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?